NDC 72162-2302-04 - Mesalamine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 72162-2302
- Requested NDC
- 72162-2302-04
- Package NDCs from labels
- 72162-2302-2, 72162-2302-4, 72162-2302-04
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-05-01
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Mesalamine - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-05-01 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 72162-2302-2 | Mesalamine | 60 mL in 1 BOTTLE, DISPENSING | SUSPENSION | 60 | 101 | |
| 72162-2302-2 | Mesalamine | 7 in 1 CARTON | SUSPENSION | 7 | 101 | |
| 72162-2302-4 | Mesalamine | 60 mL in 1 BOTTLE, DISPENSING | SUSPENSION | 60 | 101 | |
| 72162-2302-4 | Mesalamine | 28 in 1 CARTON | SUSPENSION | 28 | 101 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 72162-2302 | MESALAMINE SUSPENSION [BRYANT RANCH PREPACK] | 101 | Current NDC, 4 package rows | 20240502_c9b1ef9d-1d06-48e7-87d2-7985b99124a6.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 72162-2302-2 | ML - Milliliter | 72162-2302 | 8668e8af-a56b-40ad-a885-4f1f93954c7f | 1 | 2024-06-10 |
| 72162-2302-4 | ML - Milliliter | 72162-2302 | 76f2f318-3551-4999-ba13-b20371b07f35 | 1 | 2024-06-10 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Sodium phenylacetate and Sodium benzoate | SODIUM PHENYLACETATE AND SODIUM BENZOATE | Navinta LLC | d20768fe-4516-483a-a082-ff1df9ad1d99 | 2025-12-06 | Warnings, Adverse reactions | OJ245FE5EU |
| Mesalamine | MESALAMINE | Upsher-Smith Laboratories, LLC | 1e6978d0-01db-477d-a90f-27561777480f | 2025-12-01 | Warnings, Adverse reactions | 4Q81I59GXC |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | beda35c3-9a8b-47ad-e053-2995a90a7b1b | 2025-11-24 | Warnings | 059QF0KO0R |
| Easy Care First Aid Eyewash | WATER | Tender Corporation | a070aac8-e6d2-ef10-e053-2a95a90aa5b1 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | e07a064b-f680-405c-bbcd-24fac430951e | 2025-11-24 | Warnings | 059QF0KO0R |
| ULINE Eyewash | EYEWASH | Niagara Pharmaceuticals Inc. | 2d7f22d2-320b-6af1-e063-6294a90addc6 | 2025-11-24 | Warnings | 059QF0KO0R |
| Pur-Wash | EYEWASH | Niagara Pharmaceuticals, Inc. | 0d43b1c1-2699-37f1-e054-00144ff88e88 | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 777e1559-786f-8d54-e053-2991aa0aa98d | 2025-11-24 | Warnings | 059QF0KO0R |
| PUR-WASH | WATER | Niagara Pharmaceuticals Inc. | 7289103a-5cbf-42f4-8848-e827149a43ca | 2025-11-24 | Warnings | 059QF0KO0R |
| Eyewash Additive Concentrate | WATER AND PROPYLENE GLYCOL | Haws Corporation | dd168403-398c-41ff-b1df-d93e4ff39de3 | 2025-11-20 | Warnings | 059QF0KO0R |
| Sterile Water | WATER | Fresenius Kabi USA, LLC | fd823bef-c14c-4708-a18a-8aaa8470412f | 2025-11-18 | Warnings, Adverse reactions | 059QF0KO0R |
| Eyesaline Eyewash Concentrate | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 3765c251-eb14-d60f-e063-6294a90a6a4d | 2025-11-12 | Warnings | 059QF0KO0R |
| Eyesaline Emergency Eyewash | PURIFIED WATER | Honeywell Safety Products USA, Inc. | 37f244fd-c02f-e66a-e063-6394a90aed81 | 2025-11-12 | Warnings | 059QF0KO0R |
| Bacteriostatic Water | BACTERIOSTATIC WATER | ProPharma Distribution | 42c6938e-f747-ae13-e063-6294a90a59a3 | 2025-11-04 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | aab10f03-26ae-4dbc-a481-ef025e48b405 | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | e3484bc6-ed7f-43ef-9d49-c131a8dff2dd | 2025-11-02 | Warnings, Adverse reactions | 059QF0KO0R |
| Sterile Water | WATER | ICU Medical Inc. | 1c0bbcb7-5ed6-4ee7-b297-080d3359474e | 2025-10-29 | Boxed warning, Warnings, Adverse reactions | 059QF0KO0R |
| NORMOSOL-M AND DEXTROSE | DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, POTASSIUM ACETATE, AND MAGNESIUM ACETATE | ICU Medical Inc. | aba60c84-94d9-46d0-bdbb-25e0c4e8cc41 | 2025-10-24 | Warnings, Adverse reactions | M911911U02 |
| Sterile Water | WATER | Becton Dickinson and Company | cab03cda-4660-4020-a3be-bf86242ff664 | 2025-10-22 | Warnings, Adverse reactions | 059QF0KO0R |
| Mesalamine | MESALAMINE | Encube Ethicals, Inc. | d6b68275-b2a4-4965-9862-cf14acf8c599 | 2025-10-07 | Warnings, Adverse reactions | ANDA216941 21922-045 238151 6ffc01fa-3cf5-4e6c-9760-7ff9873c82df d6b68275-b2a4-4965-9862-cf14acf8c599 4Q81I59GXC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.